KalVista Pharmaceuticals creating a new generation of small molecule protease inhibitors for HAE and DME Hereditary Angioedema (HAE)Diabetic Macular Edema (DME)
News KalVista Pharmaceuticals Appoints Brian J. G. Pereira, MD to Board of Directors Feb 1, 2019 KalVista Pharmaceuticals Provides Development Update and 2019 Clinical Plans Jan 4, 2019 KalVista Pharmaceuticals Reports Fiscal Second Quarter Results Dec 14, 2018 All News
